Eli Lilly & Co (LLY) - Diabetes Revenue (DISCONTINUED) (I:ELCLLYDR)
19.67B USD for 2023
Level Chart
Basic Info
|
Eli Lilly & Co (LLY) - Diabetes Revenue is at a current level of 19.67B, up from 14.46B one year ago. This is a change of 35.97% from one year ago. |
|
Diabetes Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to diabetes within a specific reporting period. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 19.67B |
| Latest Period | 2023 |
| Last Updated | Feb 15 2024, 08:41 EST |
| Average Growth Rate | 14.13% |
| Value from 1 Year Ago | 14.46B |
| Change from 1 Year Ago | 35.97% |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |
Historical Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.67B |
| December 31, 2022 | 14.46B |
| December 31, 2021 | 13.19B |
| December 31, 2020 | 11.83B |
| December 31, 2019 | 11.13B |
| December 31, 2018 | 9.820B |
| Date | Value |
|---|---|
| December 31, 2017 | 10.09B |
| December 31, 2016 | 8.083B |
| December 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
News
Headline
Time (ET)
Basic Info
|
Eli Lilly & Co (LLY) - Diabetes Revenue is at a current level of 19.67B, up from 14.46B one year ago. This is a change of 35.97% from one year ago. |
|
Diabetes Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to diabetes within a specific reporting period. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 19.67B |
| Latest Period | 2023 |
| Last Updated | Feb 15 2024, 08:41 EST |
| Average Growth Rate | 14.13% |
| Value from 1 Year Ago | 14.46B |
| Change from 1 Year Ago | 35.97% |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |